Transaction in Own Shares

/**/

RNS Number : 2129M CVS Group plc 19 December 2025  

19 December 2025   CVS GROUP plc ("CVS" or the "Company" and, together with its subsidiaries, the "Group") Transaction in own shares   CVS announces that on 18 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").  

Date of purchase:

18/12/2025

Aggregate number of Ordinary Shares purchased:

18,123

Lowest price paid per share (GBp):

1,248.00

Highest price paid per share (GBp):

1,268.00

Volume weighted average price paid per share (GBp):

1,257.38



CVS intends to cancel all of the purchased Ordinary Shares.   Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,783,372 Ordinary Shares in issue and holds no Ordinary Shares in treasury.   The total number of voting rights in CVS is therefore 70,783,372 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.   Since the commencement of the Share Buyback Programme, the Company has repurchased 957,411 Ordinary Shares in aggregate at a weighted average price of 1,217.39 pence per share.   In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.   Individual transactions:  

Number of Ordinary Shares purchased

Transaction price (GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading Venue

 





307

1250

18/12/2025 08:09:43

1353937584130558

XLON



102

1254

18/12/2025 08:37:43

1353937584133303

XLON



8

1254

18/12/2025 08:37:43

1353937584133304

XLON



453

1254

18/12/2025 08:37:43

1353937584133305

XLON



609

1262

18/12/2025 09:02:37

1353937584135463

XLON



255

1262

18/12/2025 09:02:37

1353937584135464

XLON



870

1264

18/12/2025 09:10:39

1353937584135960

XLON



228

1264

18/12/2025 09:16:40

1353937584136294

XLON



869

1262

18/12/2025 09:30:28

1353937584137015

XLON



760

1262

18/12/2025 09:30:28

1353937584137016

XLON



72

1258

18/12/2025 09:33:10

1353937584137105

XLON



174

1260

18/12/2025 09:57:19

1353937584138818

XLON



80

1258

18/12/2025 09:57:19

1353937584138822

XLON



70

1262

18/12/2025 10:14:15

1353937584139761

XLON



106

1260

18/12/2025 11:06:58

1353937584142803

XLON



81

1258

18/12/2025 11:38:14

1353937584143948

XLON



146

1258

18/12/2025 11:38:14

1353937584143951

XLON



105

1254

18/12/2025 11:45:05

1353937584144245

XLON



727

1252

18/12/2025 11:49:35

1353937584144455

XLON



328

1252

18/12/2025 11:49:39

1353937584144460

XLON



101

1252

18/12/2025 11:49:51

1353937584144475

XLON



774

1252

18/12/2025 11:49:54

1353937584144486

XLON



900

1250

18/12/2025 11:51:00

1353937584144598

XLON



908

1254

18/12/2025 11:59:04

1353937584144923

XLON



908

1254

18/12/2025 11:59:04

1353937584144932

XLON



901

1250

18/12/2025 12:00:26

1353937584145643

XLON



429

1250

18/12/2025 12:02:30

1353937584147471

XLON



376

1250

18/12/2025 12:02:30

1353937584147473

XLON



590

1250

18/12/2025 12:05:55

1353937584147883

XLON



622

1248

18/12/2025 12:07:00

1353937584148033

XLON



87

1248

18/12/2025 12:07:00

1353937584148034

XLON



300

1248

18/12/2025 12:13:16

1353937584149101

XLON



869

1258

18/12/2025 13:44:50

1353937584156800

XLON



376

1262

18/12/2025 14:29:32

1353937584160096

XLON



100

1260

18/12/2025 14:30:01

1353937584160298

XLON



793

1268

18/12/2025 14:55:35

1353937584164955

XLON



275

1268

18/12/2025 14:55:35

1353937584164956

XLON



275

1264

18/12/2025 15:07:55

1353937584166713

XLON



267

1264

18/12/2025 15:21:43

1353937584168395

XLON



100

1264

18/12/2025 15:21:43

1353937584168397

XLON



192

1264

18/12/2025 15:41:00

1353937584171506

XLON



144

1264

18/12/2025 15:41:00

1353937584171507

XLON



201

1264

18/12/2025 16:03:50

1353937584175041

XLON



198

1264

18/12/2025 16:03:54

1353937584175064

XLON



6

1268

18/12/2025 16:19:05

1353937584177834

XLON



258

1268

18/12/2025 16:22:43

1353937584178435

XLON



32

1268

18/12/2025 16:22:43

1353937584178436

XLON



25

1268

18/12/2025 16:22:43

1353937584178437

XLON



549

1268

18/12/2025 16:22:43

1353937584178438

XLON



217

1266

18/12/2025 16:23:21

1353937584178537

XLON



    Contacts CVS Group plc                                                                                                                                                 via Camarco Richard Fairman, CEO Robin Alfonso, CFO Paul Higgs, Chief Veterinary Officer Charlotte Page, Head of Investor Relations   Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                 +44 (0)20 7418 8900 Christopher Golden / James Steel / Andrew Clark   Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800 Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing   Camarco (Financial PR)                                                                                                                           cvsg@camarco.co.uk Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138 Letaba Rimell Tilly Butcher   About CVS Group plc (www.cvsukltd.co.uk)   CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.   The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").   The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.    

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  POSGPGMPPUPAUUB